Global Albumin Market Size study & Forecast, by Product Type, by Application, by End user and Regional Analysis, 2023-2030

Description

List of Tables

Global Albumin Market is valued at approximately USD 5.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.0% during the forecast period 2023-2030.Albumin is the predominant protein circulating in plasma and constitutes approximately half of the total protein content (3.5 g/dL to 5 g/dL) in healthy human individuals. Synthesized primarily by liver hepatocytes, albumin is promptly released into the bloodstream at a rate ranging from 10 gm to 15 gm per day. The liver retains minimal stores of albumin, with the majority swiftly entering the bloodstream. In humans, serum albumin serves as a crucial regulator of plasma oncotic pressure and facilitates the transport of both endogenous and exogenous substances, including pharmaceuticals. In clinical practice, serum albumin levels are routinely determined through standard serum laboratory assays, often utilized as an indicator of an individual patient's nutritional status. Increasing incidence of cancer among the growing population is serving as a key driver in the scope of the albumin market along with the climate of diseases in today's era is taking new forms where various drugs and vaccines are demanding the use of Albumin as a base. The rise in the Geriatric population who are less immune to the diseases and the need of Albumin in their blood movements are also a major factor for the stability of the Albumin in the medical industry.

According to World Health Organization (WHO) Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, Each year, approximately 400 000 children develop cancer where Albumin is used as a pretreatment intake for the patients to kill cancer at its initial stages. According to Statista, in 2018, more than 920 metric tons of albumin were consumed worldwide mostly for cancer diagnostics, therapies and Morbus Wilson treatments. Furthermore, the results from National Institute of Health (NIH) were, Of the 29 studies reviewed on cancers of the gastrointestinal tract, all except three found higher serum albumin levels to be associated with better survival in multivariate analysis. Of the 10 studies reviewed on lung cancer, all excepting one found higher serum albumin levels to be associated with better survival. In 6 studies reviewed on female cancers and multiple cancers each, lower levels of serum albumin were associated with poor survival. Finally, in all 8 studies reviewed on patients with other cancer sites, lower levels of serum albumin were associated with poor survival. The Research and development using modern technologies supported and aided by the Governments of various countries serves as a major opportunity for the Albumin market to grow in the forecasted period. One potential obstacle facing the Albumin market is the risk of encountering supply constraints or shortages. These limitations may arise from diverse factors including manufacturing complexities, regulatory hurdles, or disruptions within the supply chain.

The key regions considered for the Global Albumin Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to robust healthcare infrastructures, a considerable patient population, and a heightened level of research and development activities, also renowned for hosting some of the world's premier medical institutions, hospitals, and research centers, the region offers an ideal environment for the widespread adoption of albumin across various medical applications. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as susceptibility to health issues necessitating albumin utilization, such as surgical interventions, trauma management, and chronic disease treatment, which has contributed to a sustained demand for albumin within the region.

Major market player included in this report are:

Octapharma AG
Albumedix Ltd.
Biotest AG
Grifols SA
HiMedia Laboratories Pvt Ltd.
Medxbio Pte Ltd.
CSL Limited
Merck KGaA
Takeda Pharmaceutical Company Limited
Ventria Bioscience Inc

Recent Developments in the Market:

In November 2023, the FDA granted approval to Albumedix's Recombumin, a crucial component utilized in the world's inaugural chikungunya vaccine developed by Valneva. Albumedix expresses profound pride in its product's contribution to the successful delivery of this pioneering vaccine.
In July 2023, Rifols has completed the enrolment of patients in its Phase III PRECIOSA clinical trial of long-term Albutein (albumin-human injection) therapy to increase the survival time in patients with decompensated cirrhosis. Rifol have implored the survival prospects of patients suffering from decompensated cirrhosis until they can get a liver transplant, a large unmet need given the limited availability of livers for patients.
In March 2019, Takeda has obtained approval from the U.S. Food and Drug Administration (FDA) to produce FLEXBUMIN(R) at its newly established plasma manufacturing facility located near Covington, Georgia. This state-of-the-art facility underscores Takeda's commitment to supporting the ongoing expansion of its portfolio of plasma-derived therapies. It enhances our capacity to deliver these intricate therapies to patients, thereby fortifying our ability to meet the healthcare needs of individuals.

Global Albumin Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product Type, Application, End user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin

By Application:

Drug Formulation
Therapeutics
Diagnostics
Research

By End user:

Hospitals & Clinics
Pharmaceutical companies
Research institutions

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1.Executive Summary

1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1.Albumin Market, by Region, 2020-2030 (USD Billion)
- 1.2.2.Albumin Market, by Product Type, 2020-2030 (USD Billion)
- 1.2.3.Albumin Market, by Application, 2020-2030 (USD Billion)
1.3.Albumin Market, by End user, 2020-2030 (USD Billion)Key Trends
1.4.Estimation Methodology
1.5.Research Assumption

Chapter 2.Global Albumin Market Definition and Scope

2.1.Objective of the Study
2.2.Market Definition & Scope
- 2.2.1.Industry Evolution
- 2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates

Chapter 3.Global Albumin Market Dynamics

3.1.Albumin Market Impact Analysis (2020-2030)
- 3.1.1.Market Drivers
  - 3.1.1.1.Increasing incidence of cancer
  - 3.1.1.2.Growing Geriatric Population
- 3.1.2.Market Challenges
  - 3.1.2.1.High Cost of Albumin
  - 3.1.2.2.Possible manufacturing & regulatory issues
- 3.1.3.Market Opportunities
  - 3.1.3.1.Rise of Diseases with Albumin necessitation
  - 3.1.3.2.Ongoing research in Formulation of vaccines and drugs

Chapter 4.Global Albumin Market Industry Analysis

4.1.Porter's 5 Force Model
- 4.1.1.Bargaining Power of Suppliers
- 4.1.2.Bargaining Power of Buyers
- 4.1.3.Threat of New Entrants
- 4.1.4.Threat of Substitutes
- 4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
- 4.3.1.Political
- 4.3.2.Economical
- 4.3.3.Social
- 4.3.4.Technological
- 4.3.5.Environmental
- 4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Albumin Market, by Product Type

5.1.Market Snapshot
5.2.Global Albumin Market by Product Type, Performance - Potential Analysis
5.3.Global Albumin Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4.Albumin Market, Sub Segment Analysis
- 5.4.1.Human Serum Albumin
- 5.4.2.Bovine Serum Albumin
- 5.4.3.Recombinant Albumin

Chapter 6.Global Albumin Market, by Application

6.1.Market Snapshot
6.2.Global Albumin Market by Application, Performance - Potential Analysis
6.3.Global Albumin Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4.Albumin Market, Sub Segment Analysis
- 6.4.1.Drug Formulation
- 6.4.2.Therapeutics
- 6.4.3.Diagnostics
- 6.4.4.Research

Chapter 7.Global Albumin Market, by End user

7.1.Market Snapshot
7.2.Global Albumin Market by End user, Performance - Potential Analysis
7.3.Global Albumin Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
7.4.Albumin Market, Sub Segment Analysis
- 7.4.1.Hospitals & Clinics
- 7.4.2.Pharmaceutical companies
- 7.4.3.Research institutions

Chapter 8.Global Albumin Market, Regional Analysis

8.1.Top Leading Countries
8.2.Top Emerging Countries
8.3.Albumin Market, Regional Market Snapshot
8.4.North America Albumin Market
- 8.4.1.U.S. Albumin Market
  - 8.4.1.1.Product Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3.End user breakdown estimates & forecasts, 2020-2030
- 8.4.2.Canada Albumin Market
8.5.Europe Albumin Market Snapshot
- 8.5.1.U.K. Albumin Market
- 8.5.2.Germany Albumin Market
- 8.5.3.France Albumin Market
- 8.5.4.Spain Albumin Market
- 8.5.5.Italy Albumin Market
- 8.5.6.Rest of Europe Albumin Market
8.6.Asia-Pacific Albumin Market Snapshot
- 8.6.1.China Albumin Market
- 8.6.2.India Albumin Market
- 8.6.3.Japan Albumin Market
- 8.6.4.Australia Albumin Market
- 8.6.5.South Korea Albumin Market
- 8.6.6.Rest of Asia Pacific Albumin Market
8.7.Latin America Albumin Market Snapshot
- 8.7.1.Brazil Albumin Market
- 8.7.2.Mexico Albumin Market
8.8.Middle East & Africa Albumin Market
- 8.8.1.Saudi Arabia Albumin Market
- 8.8.2.South Africa Albumin Market
- 8.8.3.Rest of Middle East & Africa Albumin Market

Chapter 9.Competitive Intelligence

9.1.Key Company SWOT Analysis
9.2.Top Market Strategies
9.3.Company Profiles
- 9.3.1. Octapharma AG
  - 9.3.1.1.Key Information
  - 9.3.1.2.Overview
  - 9.3.1.3.Financial (Subject to Data Availability)
  - 9.3.1.4.Product Summary
  - 9.3.1.5.Recent Developments
- 9.3.2.Albumedix Ltd.
- 9.3.3. Biotest AG
- 9.3.4. Grifols SA
- 9.3.5. HiMedia Laboratories Pvt Ltd.
- 9.3.6. Medxbio Pte Ltd.
- 9.3.7. CSL Limited
- 9.3.8. Merck KGaA
- 9.3.9. Takeda Pharmaceutical Company Limited
- 9.3.10. Ventria Bioscience Inc.

Chapter 10.Research Process

10.1.Research Process
- 10.1.1.Data Mining
- 10.1.2.Analysis
- 10.1.3.Market Estimation
- 10.1.4.Validation
- 10.1.5.Publishing
10.2.Research Attributes
10.3.Research Assumption

LIST OF TABLES

TABLE 1.Global Albumin Market, report scope
TABLE 2.Global Albumin Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3.Global Albumin Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
TABLE 4.Global Albumin Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5.Global Albumin Market estimates & forecasts by End user 2020-2030 (USD Billion)
TABLE 6.Global Albumin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7.Global Albumin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8.Global Albumin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9.Global Albumin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10.Global Albumin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11.Global Albumin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12.Global Albumin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13.Global Albumin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14.Global Albumin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15.Global Albumin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16.U.S. Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17.U.S. Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18.U.S. Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19.Canada Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20.Canada Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21.Canada Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22.UK Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23.UK Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24.UK Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25.Germany Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26.Germany Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27.Germany Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28.France Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29.France Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30.France Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31.Italy Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32.Italy Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33.Italy Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34.Spain Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35.Spain Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36.Spain Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37.RoE Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38.RoE Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39.RoE Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40.China Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41.China Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42.China Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43.India Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44.India Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45.India Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46.Japan Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47.Japan Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48.Japan Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49.South Korea Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50.South Korea Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51.South Korea Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52.Australia Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53.Australia Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54.Australia Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55.RoAPAC Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56.RoAPAC Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57.RoAPAC Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58.Brazil Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59.Brazil Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60.Brazil Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61.Mexico Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62.Mexico Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63.Mexico Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64.RoLA Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65.RoLA Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66.RoLA Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67.Saudi Arabia Albumin Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68.South Africa Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69.RoMEA Albumin Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70.List of secondary sources, used in the study of global Albumin Market
TABLE 71.List of primary sources, used in the study of global Albumin Market
TABLE 72.Years considered for the study
TABLE 73.Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1.Global Albumin Market, research methodology
FIG 2.Global Albumin Market, Market estimation techniques
FIG 3.Global Market size estimates & forecast methods
FIG 4.Global Albumin Market, key trends 2022
FIG 5.Global Albumin Market, growth prospects 2023-2030
FIG 6.Global Albumin Market, porters 5 force model
FIG 7.Global Albumin Market, pest analysis
FIG 8.Global Albumin Market, value chain analysis
FIG 9.Global Albumin Market by segment, 2020 & 2030 (USD Billion)
FIG 10.Global Albumin Market by segment, 2020 & 2030 (USD Billion)
FIG 11.Global Albumin Market by segment, 2020 & 2030 (USD Billion)
FIG 12.Global Albumin Market by segment, 2020 & 2030 (USD Billion)
FIG 13.Global Albumin Market by segment, 2020 & 2030 (USD Billion)
FIG 14.Global Albumin Market, regional snapshot 2020 & 2030
FIG 15.North America Albumin Market 2020 & 2030 (USD Billion)
FIG 16.Europe Albumin Market 2020 & 2030 (USD Billion)
FIG 17.Asia pacific Albumin Market 2020 & 2030 (USD Billion)
FIG 18.Latin America Albumin Market 2020 & 2030 (USD Billion)
FIG 19.Middle East & Africa Albumin Market 2020 & 2030 (USD Billion)